A business in context

PLUR research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-26 · 0001213900-26-094638 · Items 1.01,3.02,9.01

  2. 4 · Ownership change

    Report date 2026-08-20 · 0001213900-26-093070

  3. 4 · Ownership change

    Report date 2026-08-20 · 0001213900-26-093064

  4. 8-K · Current report

    Report date 2026-08-12 · 0001213900-26-090738 · Items 8.01

  5. 8-K · Current report

    Report date 2026-07-14 · 0001213900-26-077960 · Items 8.01

  6. 8-K · Current report

    Report date 2026-07-07 · 0001213900-26-077548 · Items 3.01

  7. 4 · Ownership change

    Report date 2026-06-30 · 0001213900-26-074214

  8. 8-K · Current report

    Report date 2026-06-15 · 0001213900-26-070609 · Items 1.01,5.02,5.07,9.01

  9. 8-K · Current report

    Report date 2026-05-28 · 0001213900-26-063500 · Items 8.01

  10. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001213900-26-056586

  11. 4 · Ownership change

    Report date 2026-03-31 · 0001213900-26-051531

  12. DEF 14A · Proxy statement

    Report date 2026-06-15 · 0001213900-26-047070

  13. 8-K · Current report

    Report date 2026-03-25 · 0001213900-26-035110 · Items 1.01,3.02,9.01

  14. 8-K · Current report

    Report date 2026-02-27 · 0001213900-26-022025 · Items 8.01

  15. 10-Q · Quarterly report

    Report date 2025-12-31 · 0001213900-26-015550

  16. 8-K · Current report

    Report date 2026-01-20 · 0001213900-26-006685 · Items 3.01

  17. 4 · Ownership change

    Report date 2025-12-30 · 0001213900-26-001394

  18. 8-K · Current report

    Report date 2025-12-08 · 0001213900-25-119651 · Items 1.01,3.02,5.02,8.01,9.01

  19. 4 · Ownership change

    Report date 2025-12-04 · 0001213900-25-119238

  20. 4 · Ownership change

    Report date 2025-12-04 · 0001213900-25-119235

  21. 4 · Ownership change

    Report date 2025-12-04 · 0001213900-25-119234

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001213900-25-109174

  23. 8-K · Current report

    Report date 2025-10-15 · 0001213900-25-099632 · Items 5.02

  24. 10-K · Annual report

    Report date 2025-06-30 · 0001213900-25-088578

  25. 8-K · Current report

    Report date 2025-09-11 · 0001213900-25-087052 · Items 8.01

  26. 8-K · Current report

    Report date 2025-09-10 · 0001213900-25-086670 · Items 5.02

  27. 8-K · Current report

    Report date 2025-06-30 · 0001213900-25-061364 · Items 3.01,5.02,5.07

  28. DEF 14A · Proxy statement

    Report date 2025-06-30 · 0001213900-25-047783

  29. 8-K · Current report

    Report date 2025-05-21 · 0001213900-25-047562 · Items 8.01

  30. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001213900-25-042637

  31. 8-K · Current report

    Report date 2025-05-07 · 0001213900-25-040816 · Items 8.01

  32. 8-K · Current report

    Report date 2025-04-25 · 0001213900-25-036785 · Items 5.08

  33. 8-K · Current report

    Report date 2025-04-28 · 0001213900-25-035770 · Items 8.01

  34. 8-K · Current report

    Report date 2025-04-25 · 0001213900-25-035668 · Items 1.01,3.02,9.01

  35. 8-K · Current report

    Report date 2025-04-15 · 0001213900-25-032948 · Items 8.01

  36. 8-K · Current report

    Report date 2025-03-13 · 0001213900-25-025065 · Items 5.08

  37. 8-K · Current report

    Report date 2025-03-12 · 0001213900-25-023733 · Items 1.01,3.02,9.01

  38. 10-Q · Quarterly report

    Report date 2024-12-31 · 0001213900-25-012189

  39. 8-K · Current report

    Report date 2025-02-03 · 0001213900-25-010723 · Items 1.01,3.02,9.01

  40. 8-K · Current report

    Report date 2025-01-23 · 0001213900-25-007698 · Items 1.01,3.02,5.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 4 transaction rows4AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

4 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-04-21
2026-05-04
Chutzpah Holdings Ltd; Manieu Alexandre WeinsteinA · Grant / award
Acquired
Common Stock312500.02.0
2026-04-21
2026-05-04
Chutzpah Holdings Ltd; Manieu Alexandre WeinsteinA · Grant / award
Acquired
Warrants
Derivative security
312500.02.0
2026-03-31
2026-05-04
Chutzpah Holdings Ltd; Manieu Alexandre WeinsteinA · Grant / award
Acquired
Common Stock312500.02.0
2026-03-31
2026-05-04
Chutzpah Holdings Ltd; Manieu Alexandre WeinsteinA · Grant / award
Acquired
Warrants
Derivative security
312500.02.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001158780Pluri Inc.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
529900OZKMF7JGZMYM81
GLEIF legal name
Pluristem Therapeutics Inc.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2021-07-19T05:07:28Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Pluristem Therapeutics Inc. · alias · wikidata
  • PLURISTEM THERAPEUTICS INC · former SEC name · 2008-02-12 to 2022-07-13
  • PLURISTEM LIFE SYSTEMS INC · former SEC name · 2003-07-02 to 2007-12-28
  • AI SOFTWARE INC · former SEC name · 2001-11-29 to 2003-07-01
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2025-06-30$1.34M$1.40M
2024-06-30$326.0K$351.7K
2023-06-30$287.0K$319.8K
2022-06-30$234.0K$277.1K
2020-06-30$23.0K$29.9K
2019-06-30$54.0K$71.2K
2018-06-30$50.0K$67.3K

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗